We also performed IRAK4 knockdown with siRNAs in a primary MDS sample with SF3B1 mutations and observed an increase in colonies and myeloid differentiation upon knockdown, validating IRAK4 as a target for relieving the differentiation block seen in MDS (Figure 4F). This evidence concerns the gene IRAK4 and myelodysplastic syndrome.